{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:19:13Z","timestamp":1790518753422,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232140","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T17:51:05Z","timestamp":1588269065000},"page":"e0232140","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9364","authenticated-orcid":true,"given":"Valentine","family":"Faure Bardon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Patrick","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Guilleminot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"issue":"5","key":"pone.0232140.ref001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"SC Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"pone.0232140.ref002","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bpobgyn.2016.10.005","article-title":"Fetal cytomegalovirus infection","volume":"38","author":"M Leruez-Ville","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"pone.0232140.ref003","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"M Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pone.0232140.ref004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984\u20131999","volume":"70","author":"KM Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"8","key":"pone.0232140.ref005","first-page":"601","article-title":"Contributions of the ex vivo human perfused placenta in the study of placental transfer of drugs","volume":"39","author":"P-F Ceccald","year":"2010","journal-title":"J Gyn\u00e9cologie Obst\u00e9trique Biol Reprod. d\u00e9c"},{"key":"pone.0232140.ref006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000410667","article-title":"Criteria for evaluating perfusion experiments and presentation of results","volume":"13","author":"JC Challier","year":"1985","journal-title":"Contrib Gynecol Obstet"},{"issue":"6","key":"pone.0232140.ref007","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9378(72)90909-X","article-title":"Transfer across the perfused human placenta of antipyrine, sodium and leucine","volume":"114","author":"H Schneider","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0232140.ref008","unstructured":"PREVYMIS (letermovir) Tablets and PREVYMIS (letermovir) Injection. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209939Orig1s000,209940Orig1s000TOC.cfm"},{"issue":"4","key":"pone.0232140.ref009","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.47.4.1334-1342.2003","article-title":"Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects Antimicrob","volume":"47","author":"H. Wang Laurene","year":"2003","journal-title":"Agents Chemother"},{"issue":"1","key":"pone.0232140.ref010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1051\/rnd:19830104","article-title":"Flow-dependent transfer of antipyrine in the human placenta in vitro","volume":"23","author":"JC Challier","year":"1983","journal-title":"Reprod Nutr D\u00e9v"},{"issue":"8","key":"pone.0232140.ref011","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action","volume":"46","author":"KK Biron","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pone.0232140.ref012","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/bcp.13292","article-title":"Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment","volume":"83","author":"D Kropeit","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0232140.ref013","article-title":"Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus","author":"DP Melendez","year":"2015","journal-title":"Infection and Drug Resistance"},{"issue":"3","key":"pone.0232140.ref014","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246","volume":"54","author":"P Lischka","journal-title":"Antimicrob Agents Chemother"},{"issue":"25","key":"pone.0232140.ref015","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"FM Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0232140.ref016","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/clpt.2010.178","article-title":"Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections","volume":"88","author":"LK Dropulic","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"pone.0232140.ref017","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.46.8.2373-2380.2002","article-title":"Preclinical and Toxicology Studies of 1263W94, a Potent and Selective Inhibitor of Human Cytomegalovirus Replication","volume":"46","author":"GW Koszalka","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0232140.ref018","unstructured":"Efficacy and Safety Study of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir\u2014Full Text View\u2014ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02931539"},{"key":"pone.0232140.ref019","unstructured":"Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients\u2014Full Text View\u2014ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02927067"},{"issue":"1","key":"pone.0232140.ref020","first-page":"3","article-title":"Placental transfer of drugs","volume":"69","author":"D Evain-Brion","year":"2014","journal-title":"Therapie. f\u00e9vr"},{"issue":"1","key":"pone.0232140.ref021","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tiv.2012.08.027","article-title":"Placental transfer and metabolism: An overview of the experimental models utilizing human placental tissue","volume":"27","author":"P Myllynen","year":"2013","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"pone.0232140.ref022","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1128\/AAC.00075-15","article-title":"Placental Transfer of Rilpivirine in an Ex Vivo Human Cotyledon Perfusion Model","volume":"59","author":"L Mandelbrot","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0232140.ref023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajog.2006.01.017","article-title":"Placental transfer of lopinavir\/ritonavir in the ex vivo human cotyledon perfusion model","volume":"195","author":"L Gavard","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pone.0232140.ref024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAD.0000000000001681","article-title":"Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model","volume":"32","author":"V Faure-Bardon","year":"2018","journal-title":"AIDS Lond Engl"},{"issue":"5","key":"pone.0232140.ref025","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2015.06.065","article-title":"Rivaroxaban transfer across the dually perfused isolated human placental cotyledon","volume":"213","author":"P Bapat","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"pone.0232140.ref026","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1471-0528.1984.tb03700.x","article-title":"Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs","volume":"91","author":"B Krauer","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"pone.0232140.ref027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","article-title":"Fetal hepatic drug elimination","volume":"84","author":"JA Ring","year":"1999","journal-title":"Pharmacol Ther"},{"issue":"5","key":"pone.0232140.ref028","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-200262050-00004","article-title":"Fetal Pharmacotherapy","volume":"62","author":"G Koren","year":"2002","journal-title":"Drugs"},{"issue":"5","key":"pone.0232140.ref029","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.00007-16","article-title":"Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model","volume":"60","author":"C Vinot","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pone.0232140.ref030","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1128\/AAC.03184-14","article-title":"Placental transfer of darunavir in an ex vivo human cotyledon perfusion model","volume":"58","author":"L Mandelbrot","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0232140.ref031","doi-asserted-by":"crossref","first-page":"92.e1","DOI":"10.1016\/j.ajog.2011.07.023","article-title":"Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model","volume":"206","author":"P Berveiller","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0232140.ref032","unstructured":"CRAT\u2014Centre de r\u00e9f\u00e9rence sur les agents t\u00e9ratog\u00e8nes chez la femme enceinte. https:\/\/lecrat.fr\/"},{"issue":"1","key":"pone.0232140.ref033","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"L Mathiesen","year":"2010","journal-title":"Reprod Toxicol"},{"issue":"11","key":"pone.0232140.ref034","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/14767058.2016.1213807","article-title":"Placental perfusion: interest and limits","volume":"30","author":"P Berveiller","year":"2017","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T02:57:26Z","timestamp":1615517846000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232140"}},"subtitle":[],"editor":[{"given":"Frank T.","family":"Spradley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232140","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]}}}